Phase II study of cystemustine in advanced renal cancer.
Chauvergne
J
J
Kerbrat
P
P
Adenis
A
A
Chollet
P
P
Fargeot
P
P
Pujade-Lauraine
E
E
Dieras
V
V
Madelmont
J C
JC
Lentz
M A
MA
Toulouse
C
C
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; C051263:N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea